FDA Inspection 1119604 — Excell Research
The FDA completed an inspection of Excell Research on January 31, 2020 in Oceanside, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 31, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Oceanside, CA (United States)
Additional Details
Clinical BA/BE